Tatva Chintan Pharma Chem Ltd
NSE:TATVA

Watchlist Manager
Tatva Chintan Pharma Chem Ltd Logo
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Watchlist
Price: 1 743.2 INR -2.3% Market Closed
Market Cap: ₹40.8B

Wall St Price Targets

TATVA Price Forecast
Based on 7 analysts

-13% Downside
from ₹1 743.2 today

Tatva Chintan Pharma Chem Ltd (TATVA)’s 12-month stock price forecast through October 2027 has a consensus target of ₹1 519.8, implying 13% downside. The forecast is based on price targets from 7 Wall Street analysts.

TATVA Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for TATVA yet.

Tatva Chintan Pharma Chem Ltd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TATVA's stock price target?
Price Target
1 519.8 INR

According to Wall Street analysts, the average 1-year price target for TATVA is 1 519.8 INR with a low forecast of 843.35 INR and a high forecast of 2 052.75 INR.

What is the Revenue forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
26%

Over the last 6 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 26%.

What is the Gross Profit forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
36%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 36%.

What is the Operating Income forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
50%

Over the last 6 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 50%.

What is the Pre-Tax Income forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
50%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 50%.

What is the Net Income forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
51%

Over the last 6 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 51%.

Back to Top